Modified factor IX polypeptides and uses thereof

Details for Australian Patent Application No. 2010278721 (hide)

Owner Bayer HealthCare LLC

Inventors Brooks, Alan; Patel, Chandra; Jiang, Xiaoqiao; Gritzan, Uwe; Apeler, Heiner; Wang, Jun

Agent Davies Collison Cave

Pub. Number AU-A-2010278721

PCT Pub. Number WO2011/014890

Priority 61/230,551 31.07.09 US

Filing date 2 August 2010

Wipo publication date 3 February 2011

International Classifications

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014890 Priority application(s): WO2011/014890

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010278729-WD repeat 79 protein targeted therapy

2010278711-Inhibitors of cognitive decline